Exopharm Limited EX1.AX Stock
Exopharm Limited Price Chart
Exopharm Limited EX1.AX Financial and Trading Overview
| Exopharm Limited stock price | 0.01 AUD |
| Previous Close | 0.009 AUD |
| Open | 0.009 AUD |
| Bid | 0.009 AUD x 0 |
| Ask | 0.01 AUD x 0 |
| Day's Range | 0.009 - 0.009 AUD |
| 52 Week Range | 0.008 - 0.18 AUD |
| Volume | 81.11K AUD |
| Avg. Volume | 1.3M AUD |
| Market Cap | 3.95M AUD |
| Beta (5Y Monthly) | 1.381785 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EX1.AX Valuation Measures
| Enterprise Value | 1.32M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.617767 |
| Price/Book (mrq) | 0.32142854 |
| Enterprise Value/Revenue | 0.206 |
| Enterprise Value/EBITDA | -0.244 |
Trading Information
Exopharm Limited Stock Price History
| Beta (5Y Monthly) | 1.381785 |
| 52-Week Change | -94.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.18 AUD |
| 52 Week Low | 0.008 AUD |
| 50-Day Moving Average | 0.01 AUD |
| 200-Day Moving Average | 0.06 AUD |
EX1.AX Share Statistics
| Avg. Volume (3 month) | 1.3M AUD |
| Avg. Daily Volume (10-Days) | 1.03M AUD |
| Shares Outstanding | 439.42M |
| Float | 136.83M |
| Short Ratio | N/A |
| % Held by Insiders | 23.30% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -108.24% |
| Operating Margin (ttm) | -104.76% |
| Gross Margin | 37.92% |
| EBITDA Margin | -84.47% |
Management Effectiveness
| Return on Assets (ttm) | -38.51% |
| Return on Equity (ttm) | -88.24% |
Income Statement
| Revenue (ttm) | 6.4M AUD |
| Revenue Per Share (ttm) | 0.04 AUD |
| Quarterly Revenue Growth (yoy) | 4356.50% |
| Gross Profit (ttm) | 15.63K AUD |
| EBITDA | -5407976 AUD |
| Net Income Avi to Common (ttm) | -6929702 AUD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.68M AUD |
| Total Cash Per Share (mrq) | 0.01 AUD |
| Total Debt (mrq) | 1.59M AUD |
| Total Debt/Equity (mrq) | 36.19 AUD |
| Current Ratio (mrq) | 1.624 |
| Book Value Per Share (mrq) | 0.028 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6984326 AUD |
| Levered Free Cash Flow (ttm) | -5845073 AUD |
Profile of Exopharm Limited
| Country | Australia |
| State | VIC |
| City | Melbourne |
| Address | 31 Queen Street |
| ZIP | 3000 |
| Phone | 61 3 9111 0026 |
| Website | https://exopharm.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 50 |
Exopharm Limited, a clinical-stage biopharmaceutical company, develops transformative medicines based upon exosomes or extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to target them to selected tissues, organs, or cell types; LOAD technology platform enables loading active pharmaceutical ingredients into exosomes; and ligand-based exosome affinity purification technology solves the critical bottleneck of exosome isolation and purification. Its engineered EVs medicines are applied in the areas, such as neurology, cardiology, and oncology. Exopharm Limited has research collaboration agreements with Astellas Institute for Regenerative Medicine and Showa Denko Materials Co., Ltd. The company was incorporated in 2013 and is based in Melbourne, Australia.
Q&A For Exopharm Limited Stock
What is a current EX1.AX stock price?
Exopharm Limited EX1.AX stock price today per share is 0.01 AUD.
How to purchase Exopharm Limited stock?
You can buy EX1.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Exopharm Limited?
The stock symbol or ticker of Exopharm Limited is EX1.AX.
Which industry does the Exopharm Limited company belong to?
The Exopharm Limited industry is Biotechnology.
How many shares does Exopharm Limited have in circulation?
The max supply of Exopharm Limited shares is 175.77M.
What is Exopharm Limited Price to Earnings Ratio (PE Ratio)?
Exopharm Limited PE Ratio is now.
What was Exopharm Limited earnings per share over the trailing 12 months (TTM)?
Exopharm Limited EPS is -0.09 AUD over the trailing 12 months.
Which sector does the Exopharm Limited company belong to?
The Exopharm Limited sector is Healthcare.